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Summary 32 
   The demonstration of Mycobacterium tuberculosis DNA in ancient skeletons gives researchers 33 
an insight into its evolution. Findings of the last two decades sketched the biological relationships 34 
between the various species of tubercle bacilli, the time scale involved, their possible origin and 35 
dispersal. This paper includes the available evidence and on-going research. In the submerged 36 
Eastern Mediterranean Neolithic village of Atlit Yam (9000 BP), a human lineage of M. 37 
tuberculosis, defined by the TbD1 deletion in its genome, was demonstrated. An infected infant at 38 
the site provides an example of active tuberculosis in a human with a naïve immune system. Over 39 
4000 years later tuberculosis was found in Jericho. Urbanization increases population density 40 
encouraging M. tuberculosis/human co-evolution. As susceptible humans die of tuberculosis, 41 
survivors develop genetic resistance to disease. Thus in 18th century Hungarian mummies from 42 
Vác, 65% were positive for tuberculosis yet a 95-year-old woman had clearly survived a childhood 43 
Ghon lesion. 44 
   Whole genome studies are in progress, to detect changes over the millennia both in bacterial 45 
virulence and also host susceptibility/resistance genes that determine the NRAMP protein and 46 
Killer Cell Immunoglobulin-like Receptors (KIRs). This paper surveys present evidence and 47 
includes initial findings. 48 
 49 
Key words: Ancient DNA; evolution; KIR historical specimens; Mycobacterium tuberculosis; 50 
SLC11A1 gene; Solute Carrier family genes  51 
52 
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1. Introduction 53 
   Microbial infections played a key role in shaping life on earth and have been a major selector for 54 
the evolution of all present species. Evidence exists that demonstrate infectious diseases were 55 
already present in our remote ancestors.1,2 Considering the impact of Mycobacterium tuberculosis 56 
(MTB), in all probability it has had a greater influence on the genetic selection of the Homo sapiens 57 
population than any other infectious agent.   58 
   The molecular identification of human pathogens in ancient human remains has recently opened 59 
new scientific fields that provide considerable insight into the history and evolution of host, 60 
pathogen and their interaction. This allows us to track changes in the ancestral tubercle bacillus as 61 
it became more and more exposed to the internal environment and immune system of its human 62 
host. Conversely, it is possible to track changes in the genes of the human population that confer 63 
resistance or susceptibility to disease over time.  64 
   TB is related to population density,3 transmitted from human to human living in close contact. 65 
However, the origin of the disease, the earliest hosts of MTB and its evolution remain unclear. The 66 
evolution of the bacteria cannot be considered in isolation. It is important to realise how TB has 67 
influenced the human development over the millennia, particularly our resistance/susceptibility 68 
genes. MTB experienced an evolutionary bottleneck when it became an obligate pathogen and has 69 
a clonal relationship with different human lineages.4 Subsequent co-evolution has resulted in the 70 
majority of TB infections being latent. In past eras of low human population density, MTB adapted 71 
over time in response to host-adaptive changes and vice versa. This process, which can be 72 
defined as mutualism, is a biological interaction between individuals of two different species where 73 
both individuals derive a fitness benefit. As the host becomes more resistant, strains better able to 74 
colonise the resistant host will predominate, thus starting off another cycle. More virulent MTB 75 
strains will attack their human host, killing the most susceptible and leaving the more resistant as 76 
survivors. However, when human populations were sparse, this could break the chain of 77 
transmission of the pathogen. The development of antibiotics has shortened the mutualistic cycle 78 
significantly, but the combination of HIV co-infection, antimicrobial therapy and increased global 79 
human population density is leading to the emergence of some MTB strains that are both more 80 
transmissible but also more virulent.5 81 
  82 
2. The impact of palaeomicrobiological investigations of archaeological human material 83 
2.1 Questions to be addressed 84 
    Archaeologists should seek to correlate research questions with historical events. For example, 85 
did past invasions introduce new pathogens, or more virulent strains of pathogens into susceptible 86 
populations? Thousands of indigenous peoples in the Americas died from exposure to European 87 
strains of MTB, measles and smallpox.6 Another possible scenario is that invaders may have 88 
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brought new pathogens with them on return to their place of origin. A good example of this is the 89 
introduction by European colonialists of venereal syphilis from South America.  90 
    A further question one has to ask is what was the genetic status of Homo erectus or 91 
predecessor species regarding the underlying genetic basis of host resistance and susceptibility to 92 
tuberculosis. Did ancestral hominids have the precursors of modern host susceptibility/resistance 93 
genes or were these acquired late? Is the ‘Out of Africa’ theory of the origin of human TB proposed 94 
by Gutierrez et al7 capable of being verified by a study of human remains, or will these show that 95 
TB developed in several areas and that this is the explanation for the variability of the organism in 96 
different geographical areas?  97 
   The majority of TB patients in the world today never progress to active disease. The World 98 
Health Organisation estimates that approximately one-third of the global population is infected but 99 
only 10% of immunocompetent progress to active disease during their lifetime.8 Our current 100 
immunity may be the result of Darwinian selection only, or may depend upon whether particular 101 
genes are switched on or off – a mechanism that can result in rapid adaptation. It must be 102 
remembered that other non-genetic factors influence human susceptibility to infection such as 103 
dietary deficiencies, stress and trauma.9 Long-term climatic changes have an impact on vegetation 104 
and agriculture10 whereas local variations in climate may influence transmission of MTB by 105 
infectious aerosols. Temperature changes will determine whether humans spend more time in the 106 
open air or enclosed spaces, for example. 107 
2.2 Significant findings  108 
   With the first reported finding of MTB DNA in ancient skeletons based on amplification of a small 109 
(123 bp) DNA target that was specific for the MTB-complex11 a new era of research into microbial 110 
pathogen evolution became possible. In addition to skeletal remains, calcified and mummified 111 
tissues also proved to be good sources of MTB ancient DNA (aDNA)Mic 12. Our knowledge was 112 
enhanced with the finding of MTB in a 17000-year-old Pleistocene bison from Natural Trap Cave, 113 
Wyoming.13 Spoligotyping revealed that the Pleistocene bison lesions contained aDNA from the  114 
M. tuberculosis complex, possibly MTB or Mycobacterium africanum, but distinct from 115 
Mycobacterium bovis. The consensus bison spoligotyping pattern was compared with the 116 
combined database collated by the National Institute of Public Health and Environment (RIVM), 117 
Utrecht, The Netherlands and the Veterinary Science Division, Department of Agriculture and 118 
Rural Development, Belfast, N. Ireland. No exact matches were found on the database. However, 119 
in a computer analysis comparing a library of defined species, the highest similarity was from M. 120 
africanum (82.3%), then M. tuberculosis - MTB (76.6%), with M. bovis having only 72.7% similarity.  121 
    The original aDNA findings in the Pleistocene bison were confirmed ten years later by finding 122 
species-specific MTB cell wall lipid biomarkers.14 We have used this method of independent 123 
confirmation of our MTB aDNA findings since 199815 because lipid analysis uses methods based 124 
on the direct detection of femtogram quantities of target molecules, with no need for any 125 
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amplification. This is a more rigorous method of independent confirmation than sending part of the 126 
specimen to another laboratory for analysis.  127 
 128 
   The Pleistocene bison contained MTB-complex aDNA but the particular lineage has not yet been 129 
identified. The earliest known human MTB was detected and characterised in samples from the 130 
submerged Neolithic site of Atlit Yam, a 9000-year-old settlement submerged in the sea off the 131 
coast of Haifa in Israel.16 The findings were confirmed by lipid analysis and the preservation was 132 
sufficiently good that it was possible to confirm that the MTB had experienced the TbD1 deletion, 133 
found only in human lineages. This is of particular significance as this was a Pre-Pottery site with 134 
the earliest evidence of animal domestication in the Levant.  135 
   We were fortunate as a group to secure samples from two large collections of natural mummies 136 
– one from the 18th to early 19th century from Vác, Hungary and the second from early Christian 137 
Nubia dated to 500-1400 CE at Kulubnarti in Northern Sudan. The importance of these collections 138 
was that the DNA preservation is well above average as in both locations the bodies were naturally 139 
mummified with no chemicals used. Indeed, the Kulubnarti material demonstrated co-infections of 140 
MTB with Leishmania spp, and using the Hungarian material, it was possible to determine the main 141 
MTB genetic lineages and perform molecular typing.17 Our work on the Pleistocene bison together 142 
with the Hungarian Vác mummies was cited and assisted in developing the hypothesis proposed in 143 
an excellent early paper on MTB evolution by Brosch et al.18 144 
   To fill the time gap between the Nubian Kulubnarti mummies and the Attlit Yam skeletal remains, 145 
specimens from the Bronze Age township of Jericho have been examined. Initially bones from 146 
early excavations from the 1950’s were studied, in a collaboration involving colleagues from 147 
Munich, Al Quds University and Jerusalem. Unfortunately, although these specimens yielded 148 
possible MTB aDNA, this could not be confirmed independently. Material from the excavation of 149 
Ain es-Sultan refugee camp area, where ancient Jericho (Tel es-sultan) ~4000 BC has yielded 150 
MTB aDNA, which has been confirmed by lipid analysis. The infecting pathogen was from a TbD1-151 
deleted MTB lineage.  At present a metagenomic study on this specimen is in progress at 152 
McMasters University. 153 
   The Hungarian mummy project based on 265 bodies, most wholly or partially mummified, from a 154 
sealed crypt, is unique as there is contemporaneous archival information about many of the 155 
individuals. This enabled the identification of some family groups and also made it possible to 156 
study TB in a large population from a fixed period and single location.12 It was possible to type the 157 
MTB aDNA within a family and to show that each member was infected with a slightly different 158 
strain.17 Recently, lung tissue from the older daughter in this family group has been shown by non-159 
enriched whole genome sequencing, to contain two different strains of MTB, with apparent 160 
sequential deletions, that appear to be ancestral to a modern outbreak strain in Germany.19 In 161 
contrast, MTB aDNA was found in a calcified lymph node from the mediastinum of a 95-year-old 162 
mummy, where initially all tissues were negative but an X-ray showed the calcified node. This 163 
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demonstrates that in this well-preserved group of mummies it is possible to identify cases of active 164 
and of latent infection.20 It was these finding that led to our interest in host susceptibility and 165 
resistance genes. 166 
 3. Host susceptibility and resistance 167 
   In addition to the retrieval of the pathogen DNA, a pilot study is investigating the genes believed 168 
to be responsible for susceptibility or resistance to the disease to determine if these genes differ in 169 
any way between those who were infected and those who appear immune. The study of the host 170 
susceptibility/resistance factors in the mummies and their descendants will give information on the 171 
role of host genetics in the pathogenesis of infectious disease, and contribute to the design of new 172 
therapeutic strategies. The study involves two host targets, the SLC11A1 gene (previously named 173 
NRAMP) and Killer Cell Immunoglobulin-like Receptor genes (KIRs). The plan is to seek any 174 
correlation between presence and absence of tuberculosis, with the presence of certain alleles in 175 
these resistance genes. Already, our initial research on material from Hungarian and Sudanese 176 
mummies has revealed some interesting genetic patterns.  177 
   KIRs are members of a group of regulatory molecules found on subsets of lymphoid cells, first 178 
identified by their ability to impart some specificity on natural killer (NK) cytolysis. The KIR locus, 179 
which maps to chromosome 19q(13.4) within the 1 Mb Leukocyte Receptor Complex (LRC), 180 
contains a family of polymorphic and highly homologous genes. KIR genes are tandemly arrayed 181 
over a physical distance of about 150 Kb, displaying the remarkable feature of gene content 182 
variation among haplotypes. The KIR molecules recognize the Human Leukocyte Antigen (HLA) 183 
class I molecules, which are encoded by genes within the Major Histocompatibility Complex (MHC) 184 
chromosome 6.21 Interactions between KIR isotypes that inhibit natural killer (NK) cell activity and 185 
specific HLA class I allotypes protect healthy cells from spontaneous destruction by NK cell 186 
mediated cytolysis. Other KIR isotypes stimulate the activity of NK cells demonstrating that KIR 187 
play a significant role in the control of the innate immune response. Recent studies report a greater 188 
repertoire of inhibitory KIR genes among TB patients than controls22 and a direct association of 189 
certain KIR and HLA-C genes23 with resistance to pulmonary TB. Different KIR genes have a role 190 
in inhibiting or increasing susceptibility towards TB and the complimentary MHC ligands need to be 191 
tested for the functional relevance of the associated genes.24 192 
    A contemporaneous study of the SLC11A1 gene is in progress at Lake Head University. The 193 
promoter region has been studied in modern populations and been linked to a number of infections 194 
and autoimmune diseases, caused by M. tuberculosis, M. bovis, Mycobacterium leprae, 195 
Mycobacterium lepraemurium, Salmonella typhimurium and Leishmania donovani. The 196 
identification of sequence variants has prompted research into the evolution of nuclear genes, 197 
inheritance patterns, selective pressures, and changes in both allele frequencies and disease 198 
linkages over time. Linkage studies can help ascertain the resistance and susceptibility factors of 199 
diseases and can assist modern medicine by providing a better understanding of the infectious 200 
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processes themselves.25,26 The Allele 2 variation of the promoter region was found to be present in 201 
every patient infected with tuberculosis, indicating that this level of allelic expression may well be 202 
related to the resistance or susceptibility of an individual to infectious diseases. Allele 3 seems to 203 
produce the highest level of SLC11A1 expression, which confers a resistance to microbial infection 204 
to the individual, but increases susceptibility to autoimmune diseases. Conversely, Allele 2 205 
produces the lowest level of SLC11A1 expression, conferring individual resistance to autoimmune 206 
diseases, but also a greater susceptibility to microbial infections. It is possible that this 207 
contradiction in allelic expressions may have resulted from inverse selective pressures, serving to 208 
maintain both alleles within the human population. Allelic variants of SLC11A1 have been identified 209 
as risk factors for paediatric TB.27 Other studies of host susceptibility and resistance genes have 210 
indicated that different human lineages may exhibit differing susceptibilities to TB infection.28 There 211 
is also limited evidence that genetic expression may vary according to sex and age.29 An intriguing 212 
finding is that human genetic susceptibility varies according to the differing clinical forms of TB.30 213 
    Limited data are now available on amplified aDNA (Tables 1 and 2) from 18 individuals from 18th 214 
century Vác, Hungary and early Christian Nubia (Table 2). 25 The promoter microsatellite 215 
polymorphisms of the SLC11A1 gene look encouraging as patterns are emerging (Table 2). Both 216 
the KIR and SLC11A1 studies are on-going and results will be disclosed on completion. 217 
 218 
4. Conclusions  219 
   This study seeks to show the progress that has been achieved in paleomicrobiological research 220 
over the last two decades and indicates its contribution to the study of human pathogen co-221 
evolution. Understanding the adaptations that the host and the pathogen have undergone through 222 
history, together with the resistance/susceptibility adaptations, may shed light on future interactions 223 
of humans with MTB. It is highly important to understand the process of mutualism – the biological 224 
interaction between individuals of two different species, where each derives a fitness benefit  – in 225 
the present era of personalized medicine. 226 
 227 
Acknowledgements  228 
The contribution made by our many collaborators, researchers and students is gratefully 229 
acknowledged. Special acknowledgement is due to Dr Angela Gernaey (deceased) who helped 230 
pioneer the early mycolic acid work on the bison bone.  231 
 232 
Ethical approval 233 
Not required 234 
 235 
Funding 236 
Recent research has been partly supported by Hungarian National Scientific Research Foundation 237 
(OTKA) Grant No. 61166  (IP, IS). The German National Science Foundation (Deutsche 238 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 8
Forschungsgemeinschaft)- DFG grant number NE575/4-1 supported the early Jericho work. 239 
 240 
Author contributions 241 
MS conceived the original aDNA studies and HD, GKB-G, SE and CM performed experiments. 242 
HD, GKBG, CG and CM analysed ancient DNA data. MS, IH, ZA, IP and IS provided data and 243 
supplied specimens. Is S is head archaeologist of the Jericho excavations MS wrote the first and 244 
final drafts, HD prepared revised drafts and all authors approved the final version. 245 
 246 
Competing interests 247 
None declared 248 
 249 
Table legends 250 
Table 1. The SLC11A1 gene promoter microsatellite primer set  251 
Table 2. The repeats identifying each SLC11A1 allele  252 
Table 2. Genotypes of the SLC11A1 gene found in Hungarian and Nubian Mammies. 253 
254 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 9
References 255 
1. Ryan F. Tuberculosis: The greatest story never told. Bromsgrove, England: Swift 256 
Publishers, 1992. 257 
2. Roberts C. A., Pfister L A and Mays S.2009 Was Tuberculosis present in Homo Erectus in 258 
turkey American Journal of Physical Anthropology 139,442-4.  259 
3. Barnes I, Duda A, Pybus OG, Thomas MG. Ancient urbanization predicts genetic 260 
resistance to tuberculosis. Evolution 2010;65(3):842-8. 261 
4. Gagneux S. Host–pathogen coevolution in human tuberculosis. Phil Trans R Soc B 262 
2012;367 (1590):850-9. 263 
5. Basu S, Galvani AP. The evolution of tuberculosis virulence. Bull Math Biol 2009;71:1073-264 
88. 265 
6. Merbs CF. A New World of infectious disease. Ybk Phys Anthropol 1992;35:3-42. 266 
7. Gutierrez MC, Brisse S, Brosch R, Fabre M, Omaïs B, Marmiesse M, Supply P, Vincent V. 267 
Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis. PLoS 268 
Pathog 2005;1:55-61 269 
8. WHO (World Health Organization). Tuberculosis. Fact sheet No. 104. Reviewed February 270 
2013. http://www.who.int/mediacentre/factsheets/fs104/en/index.html# 271 
9. Wilbur AK, Buikstra JE. Patterns of tuberculosis in the Americas – How can modern 272 
biomedicine inform the ancient past? Mem Inst Oswaldo Cruz 2006;101(Suppl II):59-66. 273 
10. Nerlich AG, Lösch S. Paleopathology of human tubeculosis and the possible role of 274 
climate. Interdisciplinary Perspectives Infect Dis 2009; doi:10.1155/2009/437187 275 
11. Spigelman M, Lemma E. The use of the polymerase chain reaction to detect 276 
Mycobacterium tuberculosis in ancient skeletons. Int J Osteoarchaeol 1993;3:137-43. 277 
12. Fletcher HA, Donoghue HD, Holton J, Pap I, Spigelman M. Widespread occurrence of 278 
Mycobacterium tuberculosis DNA from 18th-19th century Hungarians. American Journal 279 
of Physical Anthropology 2003;120;144-52.  280 
13. Rothschild BM, Martin LD, Lev G, Bercovier H, Bar-Gal GK, Greenblatt  C, Donoghue H, 281 
Spigelman M, Brittain D. Mycobacterium tuberculosis complex DNA from an extinct Bison dated 282 
17,000 years before the present. Clin Infect Dis 2001;33(3):305-11.  283 
14. Lee OY-C, Wu HHT, Donoghue HD, Spigelman M, Greenblatt CL, Bull ID, Rothschild BM, 284 
Martin LD. Minnikin DE, Besra GS. Mycobacterium tuberculosis complex lipid virulence 285 
factors preserved in the 17,000-year-old skeleton of an extinct bison, Bison antiquus. 286 
PLoS ONE 2012;7(7): e41923. 287 
15. Donoghue HD, Spigelman M, Zias J, Gernaey-Child AM, Minnikin DE. Mycobacterium 288 
tuberculosis complex DNA in calcified pleura from remains 1400 yrs old. Lett Appl 289 
Microbiol 1998;27(5):265-9.  290 
16. Hershkovitz I, Donoghue HD, Minnikin DE, Besra GS, Lee OY-C, Gernaey AM, Galili E, 291 
Eshed V, Greenblatt CL, Lemma E, Kahila Bar-Gal G, Spigelman M. Detection and 292 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 10
molecular characterization of 9000-year-old Mycobacterium tuberculosis from a Neolithic 293 
settlement in the Eastern Mediterranean. PLoS ONE 2008;3(10), e3426. 294 
17. Fletcher HA, Donoghue HD, Taylor GM, van der Zanden AGM, Spigelman M. Molecular 295 
analysis of Mycobacterium tuberculosis from a family of 18th century Hungarians. 296 
Microbiology 2003;149:143-51. 297 
18. Brosch R, Gordon SV, Marmiesse M, Brodin P, Buchrieser C, Eiglmeier K, Garnier T, 298 
Gutierrez C, Hewinson G, Kremer K, Parsons LM, Pym AS, Samper S, van Soolingen D, 299 
Cole ST. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc 300 
Natl Acad Sci USA 2002;99:3684-9.  301 
19. Chan JZ-M, Sergeant MJ, Lee OY-C, Minnikin DE, Besra GS, Pap I, Spigelman M, 302 
Donoghue HD, Pallen MJ. Metagenomic analysis of tuberculosis in a mummy. N Engl J 303 
Med 2013;369(3):289–90. 304 
20. Donoghue HD, Pap I, Szikossy I, Spigelman M. Detection and characterization of 305 
Mycobacterium tuberculosis DNA in 18th century Hungarians with pulmonary and extra-306 
pulmonary tuberculosis, In: Yearbook of Mummy Studies 1, Gill-Frerking G, Rosendahl W, 307 
Zink A, Piombino-Mascali D, 2011, pp. 51–6, Verlag Dr. Friedrich Pfeil, Münich, Germany. 308 
21. Yen J-H, Moore BE, Nakajima T, Scholl D, Schaid DJ, Weyand CM, Goronzy JJ.  Major 309 
histocompatibility complex class I-recognizing receptors are disease risk genes in 310 
rheumatoid arthritis. J exp Med 2001;193(10):1159-68. 311 
22. Mahfouz R, Halas H, Hoteit R, Saadeh M, Shamseddeen W, Charafeddine K, Itani L, Araj 312 
GF. Study of KIR genes in Lebanese patients with tuberculosis. Int J Tuberc Lung Dis 313 
2011;15(12):1688-90. 314 
23. Lu C, Bai XL, Shen YJ, Deng YF, Wang CY, Fan G, Chu JX, Zhao SM, Zhang BC, Zhao 315 
YR, Zhang CZ, Ye H, Lu ZM. Potential implication of activating killer cell immunoglobulin-316 
like receptor and HLA in onset of pulmonary tuberculosis. Scand J Immunol 2012;76:491-317 
6.  318 
24. Pydi SS, Sunder SR, Venkatasubramanian S, Kovvali S, Jonnalagada S, Valluri VL. Killer 319 
cell immunoglobulin like receptor gene association with tuberculosis. Hum Immunol 320 
2013;74:85-92. 321 
25. Bellamy R, Ruwende C, Corrah T, McAdam KPWJ, Whittle HC, Hill AVS. Variations in the 322 
NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Eng J Med 1998;338: 323 
640-4. 324 
26. Searle S, Blackwell JM. Evidence for a functional repeat polymorphisms in the promoter of 325 
the human NRAMP1 gene that correlates with autoimmune versus infectious disease 326 
susceptibility. J Med Genet 1999;36:295-9. 327 
27. Malik S, Abel L, Tooker H, Poon A, Simkin L, Girard M, Adams GJ, Starke JR, Smith KC, 328 
Graviss EA, Musser JM, Schurr E. Alleles of the NRAMP1 gene are risk factors for 329 
pediatric tuberculosis disease. PNAS 2005;102(34):12183-8. 330 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 11
28. Azad AK, Sadee W, Schlesinger LS. Innate immune gene polymorphisms in tuberculosis. 331 
Infect Immun 2012;80(10):3343-59. 332 
29. Leung KH, Yip SP, Wong WS, Yiu LS, Chan KK, Lai WM, Chow EYD, Lin CK, Yam WC, 333 
Chan KS. Sex- and age-dependent association of SLCIIAI polymorphisms with 334 
tuberculosis in Chinese: a case control study. BMC Infect Dis 2007;7:19 (9 pages). 335 
30. Taype CA, Shamsuzzaman S, Accinelli RA, Espinoza JR, Shaw M-A. Genetic 336 
susceptibility to different clinical forms of tuberculosis in the Peruvian population. Infect 337 
Genet Evol 2010;10:495-504. 338 
 339 
 340 
 341 
  342 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 12
 343 
 344 
  Table 1. The SLC11A1 gene promoter microsatellite primer set  345 
Primer Sequence 
C1        ACT CGC ATT AGG CCA ACG AG     
C2(FAM)* (6FAM) TTC TGT GCC TCC CAA GTT AGC 
• The antisense primer marked with florescence dye  346 
• The primer was published by Bellamy et al., 199825 347 
   348 
Table 2. Genotypes of the SLC11A1 gene found in Hungarian and Nubian Mammies 349 
Sample Allele Genotype M. tuberculosis infection 
1 2/3 Heterozygote Positive chest  
2 2/3 Heterozygote Positive chest  
3 2 Homozygote Positive chest and abdomen 
4 2 Homozygote Positive chest and abdomen 
5 2 Homozygote Positive chest and abdomen 
6 2/3 
Heterozygote Positive right lung and 
abdomen 
7 2 Homozygote Positive chest  
8 2/3 
Heterozygote Positive chest, abdomen and 
pluera 
9 3 
Homozygote Positive left chest, left lung, 
left pelvis and abdominal wall 
10 #  Positive soft tissue, pleura, rib 
11 3 Homozygote Not Infected 
12 3 Homozygote Not Infected 
13 3 Homozygote Not Infected 
14 2/4 Heterozygote Unknown 
15 3/4 Heterozygote Unknown 
# Mutation present – to be confirmed 350 
Allele 1(201bp) = A(CA)5TG(CA)5TG(CA)11C; Allele 2(199bp) = A(CA)5TG(CA)5TG(CA)10C; 351 
Allele 3 (197bp) = A(CA)5TG(CA)5TG(CA)9C; Allele 4(199bp) =  A(CA)5TG(CA)9C 352 
 353 
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Figure 1: Co-evolution between human and 
pathogens  
Evolution of one species in response to 
characteristics of another 
Human Pathogen 
 
 
